Literature DB >> 27015737

Sustained release of neurotrophin-3 via calcium phosphate-coated sutures promotes axonal regeneration after spinal cord injury.

Amgad Hanna1, Daniel L Thompson1,2, Daniel J Hellenbrand1,2, Jae-Sung Lee2,3, Casey J Madura1, Meredith G Wesley1, Natalie J Dillon1, Tapan Sharma1, Connor J Enright1, William L Murphy2,3.   

Abstract

Because of the dynamics of spinal cord injury (SCI), the optimal treatment will almost certainly be a combination approach to control the environment and promote axonal growth. This study uses peripheral nerve grafts (PNGs) as scaffolds for axonal growth while delivering neurotrophin-3 (NT-3) via calcium phosphate (CaP) coatings on surgical sutures. CaP coating was grown on sutures, and NT-3 binding and release were characterized in vitro. Then, the NT-3-loaded sutures were tested in a complete SCI model. Rats were analyzed for functional improvement and axonal growth into the grafts. The CaP-coated sutures exhibited a burst release of NT-3, followed by a sustained release for at least 20 days. Functionally, the rats with PNGs + NT-3-loaded sutures and the rats treated with PNGs scored significantly higher than controls on day 56 postoperatively. However, functional scores in rats treated with PNGs + NT-3-loaded suture were not significantly different from those of rats treated with PNGs alone. Cholera toxin subunit B (CTB) labeling rostral to the graft was not observed in any controls, but CTB labeling rostral to the graft was observed in almost all rats that had had a PNG. Neurofilament labeling on transverse sections of the graft revealed that the rats treated with the NT-3-loaded sutures had significantly more axons per graft than rats treated with an NT-3 injection and rats without NT-3. These data demonstrate that PNGs serve as scaffolds for axonal growth after SCI and that CaP-coated sutures can efficiently release NT-3 to increase axonal regeneration.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  RRID:AB_2532999; RRID:AB_2535788; RRID:AB_641021; calcium phosphate coating; neurotrophin-3; peripheral nerve grafts; regeneration

Mesh:

Substances:

Year:  2016        PMID: 27015737     DOI: 10.1002/jnr.23730

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Functional recovery after peripheral nerve injury via sustained growth factor delivery from mineral-coated microparticles.

Authors:  Daniel J Hellenbrand; Clayton L Haldeman; Jae-Sung Lee; Angela G Gableman; Elena K Dai; Stephen D Ortmann; Jerrod C Gotchy; Kierra K Miller; Adrianna M Doucas; Nicole C Nowak; William L Murphy; Amgad S Hanna
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

2.  Cell Type Influences Local Delivery of Biomolecules from a Bioinspired Apatite Drug Delivery System.

Authors:  Jumana Alhamdi; Emily Jacobs; Gloria Gronowicz; Nadia Benkirane-Jessel; Marja Hurley; Liisa Kuhn
Journal:  Materials (Basel)       Date:  2018-09-13       Impact factor: 3.623

3.  Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury.

Authors:  Stephen D Ortmann; Daniel J Hellenbrand
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

4.  Treating spinal cord injury via sustained drug delivery from calcium phosphate coatings.

Authors:  Daniel J Hellenbrand; Amgad Hanna
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

5.  Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins.

Authors:  Andrew S Khalil; Xiaohua Yu; Jennifer M Umhoefer; Connie S Chamberlain; Linzie A Wildenauer; Gaoussou M Diarra; Timothy A Hacker; William L Murphy
Journal:  Sci Adv       Date:  2020-07-01       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.